International Conference On Orphan Drugs and Rare Diseases

August 17-19, 2023

August 17 -19, 2023 | Online Event

Rare Diseases and Ultra Rare Diseases

Rare Diseases and Ultra Rare Diseases

Interest in rare diseases has expanded in recent years, as evidenced by politicians' and health authorities' agendas, yet ultra-rare diseases still receive far too little attention. Although no legal classification of an "ultra-rare" disease has been created, the National Institute for Health and Care Excellence has informally designated this subcategory for medications having indications for disorders with a prevalence of less than one in per 50 000 people. The approach by which ultra-rare disease research should be conducted, as well as the question of quality, are both critical considerations. Although less stringent criteria may be used for orphan pharmaceuticals than for drugs treating more prevalent diseases, this should not be used as an excuse to deny people with rare diseases the best available treatment. When a patient is diagnosed with a rare or ultra-rare condition, having the correct physician and treatment plan is just as vital as having a support system.

  • Ultra-Rare Disease
  • Diagnosis
  • Drug Development
  • Caregivers’ Role
Orphan Drugs 2023 Speakers
Speaker at Orphan Drugs and Rare Diseases 2023 - Vicki Ratner

Vicki Ratner

ESSIC - International Society for the Study of BPS, United States
Speaker at Orphan Drugs and Rare Diseases 2023 - Kondakova O. B

Kondakova O. B

National Medical Research Center for Children's Health Federal state autonomous institution of the Russian Federation Ministry of Health, Russian Federation
Speaker at Orphan Drugs and Rare Diseases 2023 - Paul L Kaufman

Paul L Kaufman

University of Wisconsin-Madison, United States
Speaker at Orphan Drugs and Rare Diseases 2023 - Magali Taiel

Magali Taiel

GenSight Biologics, France

Submit your abstract Today

Watsapp